Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, ...

Shares of Palatin Technologies, Inc. (PTN) gained 16% on Monday after the company announces completion of patient enrollment in phase ...

Both LUNA and OPTIC were designed to assess a broad wet AMD population, including hard-to-treat patients with severe disease ...

Oral corticosteroids are anti-inflammatory medications that are the mainstay treatment for PMR. Corticosteroids, like prednisone, are highly effective, and patients often experience a significant ...

Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ...

Many people with sleep apnea benefit from oral devices that pull the lower jaw forward and hold it there, enlarging the ...

The 2025 GOLD COPD report has a new emphasis on CV disease and PH in COPD and major updates on new drugs, climate change, and ...

Anyone who regularly suffers from migraine attacks knows just how debilitating this brain pain can be (and how hard it is to ...

Metformin and GLP-1 receptor agonists significantly reduce asthma attacks in patients with type 2 diabetes, offering ...

Advances in cardiac imaging techniques and risk categorization have led to improvements in diagnosis, initial treatment and ...

Brensocatib, an oral small-molecule inhibitor targeting dipeptidyl ... help alleviate airway obstruction, while corticosteroids are used to address inflammation, although their role remains limited ...

When you hear that your dog has an infection, you’re most likely thinking of a bacterial or viral infection. However, viruses ...